EDT — Spectral Medical Income Statement
0.000.00%
Last trade - 00:00- CA$250.90m
- CA$264.52m
- CA$2.29m
Annual income statement for Spectral Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.1 | 2.05 | 1.67 | 1.6 | 2.29 |
| Cost of Revenue | |||||
| Gross Profit | 1.47 | 1.22 | 0.983 | 0.662 | 1.02 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 11.2 | 10.8 | 9.26 | 17.1 | 17.7 |
| Operating Profit | -9.1 | -8.79 | -7.6 | -15.5 | -15.4 |
| Net Income Before Taxes | -9.1 | -8.79 | -7.6 | -15.5 | -15.4 |
| Net Income After Taxes | -9.1 | -8.79 | -7.6 | -15.5 | -15.4 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -9.1 | -8.79 | -11.3 | -15.7 | -15.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.1 | -8.79 | -11.3 | -15.7 | -15.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.039 | -0.035 | -0.028 | -0.054 | -0.055 |